Philip L. Chin
- Molecular Biology top 10%
- Oncology
- Cancer Research top 10%
- Surgery
- Cell Biology top 10%
- Co-authors
- Gerd P. PfeiferJung‐Hoon YoonSteven BatesReinhard DammannChun LiJamil MomandDavid Z. J. ChuRoderich E. Schwarz
- Topics
- Bariatric Surgery and Outcomes (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Lung Cancer Treatments and Mutations (3 papers)
- Journals
- Nature GeneticsCancerOncogene
- Partner nations
- United States
In The Last Decade
Philip L. Chin
11 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Molecular Biology 878
- Oncology 228
- Cancer Research 182
- Surgery 145
- Cell Biology 139
Countries citing papers authored by Philip L. Chin
This map shows the geographic impact of Philip L. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip L. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip L. Chin more than expected).
Fields of papers citing papers by Philip L. Chin
This network shows the impact of papers produced by Philip L. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip L. Chin. The network helps show where Philip L. Chin may publish in the future.
Co-authorship network of co-authors of Philip L. Chin
This figure shows the co-authorship network connecting the top 25 collaborators of Philip L. Chin. A scholar is included among the top collaborators of Philip L. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip L. Chin. Philip L. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 24 | |
| 3 | 30 | |
| 4 | 10 | |
| 5 | Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3breakdown → | 912 |
| 6 | 27 | |
| 7 | 20 | |
| 8 | 4 | |
| 9 | 7 | |
| 10 | 32 | |
| 11 | 70 |
About Philip L. Chin
Philip L. Chin is a scholar working on Hepatology, Internal Medicine and Pharmacy, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bariatric Surgery and Outcomes (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Molecular Biology (878 citations), Cancer Research (182 citations) and Cell Biology (139 citations). Philip L. Chin has collaborated with scholars based in United States. Frequent co-authors include Gerd P. Pfeifer, Jung‐Hoon Yoon, Steven Bates, Reinhard Dammann, Chun Li, Jamil Momand, David Z. J. Chu, Roderich E. Schwarz, Mir Amaan Ali and L. Jeffrey Medeiros. Their work appears in journals such as Nature Genetics, Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.